The evidence base
The Science Behind Our Service
Why we treat the causes, not only the symptoms, the evidence for addressing the social determinants of mental health, and for connection, belonging and purpose as a powerful, effective and lasting intervention.
In summary
Treating the causes, not only the symptoms
The mental health difficulties experienced by the people we support rarely begin in the brain. They begin in circumstances: poverty, debt, insecure housing, unemployment, isolation, bereavement and adversity. The most comprehensive recent review of the field concludes that social determinants are among the strongest and most modifiable causes of mental disorder across the life course [1]. A model that responds to socially caused distress with medication alone treats the symptom while leaving the cause untouched.
This is not an alternative reading of the evidence; it is the mainstream one. NICE’s current depression guideline states that antidepressants should not routinely be offered as first-line treatment for less severe depression, recommending group, behavioural and social interventions ahead of medication [6]. Randomised trials show structured social-connection programmes match CBT for depression and outperform it for loneliness at twelve-month follow-up [10]. And unlike medication, the benefits of connection do not stop when the prescription does.
Why connection matters
The scale of the effect
1, The foundation
Mental health is socially determined
The evidence that social conditions cause and worsen mental ill health is now overwhelming. A 2024 umbrella review in World Psychiatry finds consistent, dose-dependent relationships between mental disorder and poverty, income inequality, unemployment, housing insecurity, childhood adversity, discrimination and social isolation, and concludes that responding to mental ill health requires action on these determinants, not clinical treatment alone [1]. The World Health Organization reached the same conclusion, establishing a global Commission on Social Connection [2].
For the people we support, this is not abstract. Distress that arises from a cold house, an empty week, a debt letter or the loss of every meaningful role is a proportionate human response to circumstances, and it is the circumstances a rational service must address.
The physical stakes
- Stronger social relationships are linked to a 50% increased likelihood of survival, across 148 studies of 308,849 people [3].
- Loneliness is associated with a 26% rise in premature mortality, social isolation 29%, and living alone 32% [4].
2, The limits of medication
Why medication alone cannot be the answer
Antidepressants have a legitimate place, particularly in severe illness, and no one should stop prescribed medication except with their prescriber. But the evidence is clear about their limits for the mild-to-moderate, socially driven distress most community services see.
Limited benefit at lower severity
A patient-level meta-analysis in JAMA found the benefit of antidepressants over placebo “may be minimal or nonexistent” in mild or moderate symptoms, becoming substantial only in very severe depression [5].
NICE no longer recommends them first
NICE guideline NG222 (2022) states antidepressants should not routinely be offered as first-line treatment for less severe depression, guided self-help and group CBT, behavioural activation, exercise and mindfulness are recommended ahead of medication [6].
Benefits often end when the tablets do
Abruptly stopping long-term antidepressants roughly doubles the hazard of relapse without structured support [7], while psychological interventions significantly reduce relapse risk over 24 months [13].
This is not an argument against medication for those who need it. It is that for many of the people we support, medication addresses neither the cause of their distress nor its recurrence, and the treatments the evidence ranks first are precisely the group-based, social and behavioural interventions we provide.
3, Connection as treatment
The ‘social cure’
A substantial body of research, the social identity approach to health, shows that group belonging is not a pleasant by-product of good mental health but an active therapeutic ingredient. Among people who were depressed, joining one group cut relapse risk from 41% to 31%, and joining three groups cut it to 15% [8]. Crucially, it is identification with a group, feeling you belong and that the group is part of who you are, that predicts recovery, over and above mere frequency of contact [9].
This has been tested against the best psychological therapy we have. A phase 3 randomised trial in the British Journal of Psychiatry compared Groups 4 Health, a five-session belonging programme, against dose-matched group CBT in 174 young people with depression and loneliness. Groups 4 Health matched CBT for depression and beat it for loneliness, with the advantage growing after treatment ended and holding at twelve months [10]. A treatment whose benefits increase after it finishes is the signature of something that changes lives rather than manages symptoms.
Why it lasts
Connection supplies what medication cannot: meaning, purpose, identity, practical support, reasons to get up, and people who notice when you don’t. These resources stay in a person’s life after a service ends, compound as networks grow, and carry no withdrawal effects, no side-effect burden and no dependency.
4, In the real world
Social prescribing works, clinically and economically
The applied evidence mirrors the trials. The National Academy for Social Prescribing reports that social prescribing improves wellbeing and reduces anxiety and depression, with a randomised controlled trial in Bristol showing significant improvements in anxiety, quality of life and daily functioning, and the national Green Social Prescribing evaluation showing significant reductions in anxiety and depression at favourable cost [11]. A longitudinal study framed explicitly as a ‘social cure’ found that increased social connectedness predicted the gains participants made [12].
The system benefits too: a review in the London Borough of Merton found social prescribing reduced GP appointments by 33% and A&E attendance by 50% among participants [11]. Addressing causes upstream reduces cost downstream.
5, In practice
What this means for Wye Dean Wellbeing
Our focus on social determinants is not a departure from evidence-based practice; it is its application. Alongside emotional support, we work on the conditions producing the distress.
Membership, not attendance
Group-based activity designed so people gain a genuine social identity, because identification, not contact, is what drives recovery [9].
Determinants addressed directly
Help with housing, debt, benefits, employment and access to services, because a person cannot be counselled out of circumstances that keep re-injuring them [1].
Contribution, not just care
Volunteering, skill-sharing and community roles, turning people from recipients of care into contributors, the strongest protector against relapse [8].
Working with clinical care
We never advise anyone to stop medication; prescribing belongs with prescribers. We provide the first-line, NICE-recommended layer of support that medication cannot [6].
The case, in one sentence
The distress of the people we support is largely caused by disconnection, insecurity and loss of purpose; the treatments national guidance now ranks first are social, not pharmacological; and the social cure is the only intervention whose effects strengthen after it ends, because what it builds stays in a person’s life.
References
[1] Kirkbride JB, Anglin DM, Colman I, et al. (2024). The social determinants of mental health and disorder: evidence, prevention and recommendations. World Psychiatry, 23(1), 58–90.
[2] World Health Organization (2025). From loneliness to social connection: charting a path to healthier societies. Report of the WHO Commission on Social Connection. Geneva: WHO.
[3] Holt-Lunstad J, Smith TB, Layton JB (2010). Social relationships and mortality risk: a meta-analytic review. PLOS Medicine, 7(7), e1000316.
[4] Holt-Lunstad J, Smith TB, Baker M, Harris T, Stephenson D (2015). Loneliness and social isolation as risk factors for mortality: a meta-analytic review. Perspectives on Psychological Science, 10(2), 227–237.
[5] Fournier JC, DeRubeis RJ, Hollon SD, et al. (2010). Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA, 303(1), 47–53.
[6] National Institute for Health and Care Excellence (2022). Depression in adults: treatment and management. NICE guideline NG222.
[7] Van Leeuwen E, van Driel ML, Horowitz MA, et al. (2021). Approaches for discontinuation versus continuation of long-term antidepressant use. Cochrane Database of Systematic Reviews, 4, CD013495.
[8] Cruwys T, Dingle GA, Haslam C, Haslam SA, Jetten J, Morton TA (2013). Social group memberships protect against future depression, alleviate symptoms and prevent relapse. Social Science & Medicine, 98, 179–186.
[9] Cruwys T, Haslam SA, Dingle GA, et al. (2014). Feeling connected again: interventions that increase social identification reduce depression symptoms. Journal of Affective Disorders, 159, 139–146.
[10] Cruwys T, Haslam C, Rathbone JA, Williams E, Haslam SA, Walter ZC (2022). Groups 4 Health versus CBT for depression and loneliness in young people: randomised phase 3 non-inferiority trial. British Journal of Psychiatry, 220(3), 140–147.
[11] National Academy for Social Prescribing (2024). Evidence note: social prescribing and mental health; and NASP evidence reviews on economic impact.
[12] Wakefield JRH, Kellezi B, Stevenson C, et al. (2022). Social prescribing as ‘social cure’: a longitudinal study of the health benefits of social connectedness. Journal of Health Psychology, 27(2), 386–396.
[13] Krijnen-de Bruin E, Scholten W, Muntingh A, et al. (2022). Psychological interventions to prevent relapse in anxiety and depression: a systematic review and meta-analysis. PLoS ONE, 17(8), e0272200.